NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Bhattacharya S, Middleton LJ, Tsourapas A, et al. ; the International Heavy Menstrual Bleeding Individual Patient Data Meta-analysis Collaborative Group Hysterectomy, Endometrial Ablation and Mirena® for Heavy Menstrual Bleeding: A Systematic Review of Clinical Effectiveness and Cost-Effectiveness Analysis. Southampton (UK): NIHR Evaluation, Trials and Studies Coordinating Centre (UK); 2011 Apr. (Health Technology Assessment, No. 15.19.)

Cover of Hysterectomy, Endometrial Ablation and Mirena® for Heavy Menstrual Bleeding: A Systematic Review of Clinical Effectiveness and Cost-Effectiveness Analysis

Hysterectomy, Endometrial Ablation and Mirena® for Heavy Menstrual Bleeding: A Systematic Review of Clinical Effectiveness and Cost-Effectiveness Analysis.

Show details

Appendix 10PRISMA checklist

Section/topic#Checklist itemReported on page #
Title
Title1Identify the report as a systematic review, meta-analysis or both11
Abstract
Structured summary2Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration numberN/A
Introduction
Rationale3Describe the rationale for the review in the context of what is already known11
Objectives4Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS)11
Methods
Protocol and registration5Indicate if a review protocol exists, if and where it can be accessed (e.g. URL), and, if available, provide registration information including registration number11
Eligibility criteria6Specify study characteristics (e.g. PICOS, length of follow-up) and report characteristics (e.g. years considered, language, publication status) used as criteria for eligibility, giving rationale11
Information sources7Describe all information sources (e.g. databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched11
Search8Present full electronic search strategy for at least one database, including any limits used, such that it could be repeatedAppendix 1
Study selection9State the process for selecting studies (i.e. screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis)12
Data collection process10Describe method of data extraction from reports (e.g. piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators12
Data items11List and define all variables for which data were sought (e.g. PICOS, funding sources) and any assumptions and simplifications made12, 13
Risk of bias in individual studies12Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis13
Summary measures13State the principal summary measures (e.g. risk ratio, difference in means)13
Synthesis of results14Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g. I2) for each meta-analysis13
Risk of bias across studies15Specify any assessment of risk of bias that may affect the cumulative evidence (e.g. publication bias, selective reporting within studies)13
Additional analyses16Describe methods of additional analyses (e.g. sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified13, 14
Results
Study selection17Give numbers of studies screened, assessed for eligibility and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram13, 14, Figure 1
Study characteristics18For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citationsAppendix 2
Risk of bias within studies19Present data on risk of bias of each study and, if available, any outcome level assessment (see Item 12)15,16, Figure 2, Appendix 3
Results of individual studies20For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group; (b) effect estimates and confidence intervals, ideally with a forest plot17–22, Figures 36, Appendices 48
Synthesis of results21Present results of each meta-analysis done, including confidence intervals and measures of consistency17–22, Figures 36, Appendices 48
Risk of bias across studies22Present results of any assessment of risk of bias across studies (see Item 15)17–22
Additional analysis23Give results of additional analyses, if done (e.g. sensitivity or subgroup analyses, meta-regression) (see Item 16)17–22
Discussion
Summary of evidence24Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g. health-care providers, users and policy makers)22, 23
Limitations25Discuss limitations at study and outcome level (e.g. risk of bias) and at review level (e.g. incomplete retrieval of identified research, reporting bias)23
Conclusions26Provide a general interpretation of the results in the context of other evidence and implications for future research24
Funding
Funding27Describe sources of funding for the systematic review and other support (e.g. supply of data); role of funders for the systematic reviewN/A

For more information, visit: www​.prisma-statement.org.

© 2011, Crown Copyright.

Included under terms of UK Non-commercial Government License.

Bookshelf ID: NBK99741
PubReader format: click here to try

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (10M)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...